SCHEMBL8970570

SCHEMBL8970570

CCOC(CP(=O)(OCC)C(F)F)OCC

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36
TP53 P04637 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL508153 0.74 TSHR (0.50) TSHRTP53TDP1
SCHEMBL16975426 0.72 TSHR (0.40) TSHRTP53TDP1
SCHEMBL4617525 0.67 FDPS (0.41)
SCHEMBL29249469 0.67 THRB (0.35) TSHR
SCHEMBL8971372 0.67 CYP1A2 (0.44) TSHR
SCHEMBL193239 0.66 TSHR (0.48) TSHRTP53TDP1
SCHEMBL5594316 0.66 FOLH1 (0.35) TSHR
SCHEMBL11217298 0.66 TSHR (0.33) TSHR
SCHEMBL8971494 0.65 ACHE (0.36) TSHRTP53TDP1
SCHEMBL7650811 0.65 MEN1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5567840-A AS 4-AMINOBUTYRIC ACID AGONIST; MUSCLE RELAXANTS CIBA-GEIGY CORPORATION (US) 1996-10-22 US disclosed
US-5461040-A Therapy of spinal spacticity, multiple sclerosis, cerebral palsy, trigeminus neuralgia, drug withdrawal, pain CIBA-GEIGY CORPORATION (US) 1995-10-24 US disclosed
EP-0399949-B1 Substituted aminoalkylphosphinic acids CIBA GEIGY AG (CH) 1995-04-12 EP disclosed
US-5281747-A Pharmaceuticals CIBA-GEIGY CORPORATION (US) 1994-01-25 US disclosed
EP-0399949-A1 Substituted aminoalkylphosphinic acids CIBA-GEIGY AG (CH) 1990-11-28 EP disclosed